Farther Finance Advisors’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260 Buy
62
+52
+520% +$224 ﹤0.01% 5673
2026
Q1
$38 Buy
+10
New +$42 ﹤0.01% 5600
2025
Q4
Sell
-6,291
Closed -$32.1K 5568
2025
Q3
$32.1K Buy
+6,291
New +$32.8K ﹤0.01% 2726

Other funds holding RCEL

Farther Finance Advisors's RCEL Position: Q2 2026 in Review

Farther Finance Advisors increased its Avita Medical (RCEL) stake by 520% in Q2 2026, buying an estimated $224 and bringing the position to 62 shares worth $260. The position accounts for ﹤0.01% of the portfolio, ranked #5673.

Farther Finance Advisors first reported a position in RCEL in Q3 2025 and has held it in 3 quarters since. The position peaked at $32.1K in Q3 2025. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Farther Finance Advisors held 62 shares of Avita Medical worth $260 as of Q2 2026.
  • Farther Finance Advisors bought 52 Avita Medical shares in Q2 2026, an estimated $224.
  • Avita Medical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5673 holding.
  • Farther Finance Advisors first reported a position in Avita Medical in Q3 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's Avita Medical position peaked at $32.1K in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.